跳至主要内容
临床试验/NCT03696056
NCT03696056已完成不适用

Improving Cognition in Breast Cancer Survivors Using Meditation: A Pilot Study

University of Texas at Austin2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2018年9月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
Verbal learning and memory performance-Hopkins Verbal Learning Test Immediate and Delayed Recall

研究概览

简要总结

This study will explore the feasibility and potential effects of a simple, home-based daily meditation intervention on breast cancer survivors' cognitive and psychological functioning as well as inflammatory regulation.

详细描述

This study will compare two home based 8-week interventions (Kirtan Kriya meditation vs.

relaxing instrumental music listening) in 40 breast cancer survivors ages 21-75 who completed chemotherapy 3 months to 5 years prior.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals with a history of non-inflammatory breast cancer (stages I-IV):
  • Received chemotherapy as part of their treatment
  • Completed chemotherapy treatment 3 months to 10 years prior to study enrollment
  • Individuals who have report cognitive deficits

排除标准

  • Breast cancer survivors with a history of metastases to the brain
  • A physician diagnosis of: dementia, a learning disability, unmanaged major depression, psychosis, schizophrenia, bipolar, traumatic brain injury, cancer of the central nervous system, diabetes, arthritis
  • Taking oral steroids within 30 days of enrolling
  • A regular meditation practice (greater than 1 time per week)
  • Currently taking immune modifying medications

结局指标

主要结局

Verbal learning and memory performance-Hopkins Verbal Learning Test Immediate and Delayed Recall

时间窗: Baseline, Time 2 (8 weeks after baseline), and Time 3 (16 weeks after baseline).

The change of the Hopkins Verbal Learning Test-Revised scores for immediate and delayed recall from baseline to Time 3 (16 weeks after baseline) will be assessed. This test measures immediate and delayed verbal memory. Measured as words recalled and adjusted for age and education. Higher words recalled suggests greater verbal learning and memory performance.

Executive Functioning Performance- Trail Making Test Parts A & B

时间窗: Baseline, Time 2 (8 weeks after baseline), and Time 3 (16 weeks after baseline).

The change in Trails A \& B scores, a measure of processing speed and executive attention, from baseline to Time 3 (16 weeks after baseline) will be assessed. Where time until completion is measured and adjusted for age and education. Faster time until completion suggests higher executive function.

Verbal Fluency Performance-Controlled Oral Word Association Test

时间窗: Baseline, Time 2 (8 weeks after baseline), and Time 3 (16 weeks after baseline).

The change of the Controlled Oral Word Association Test, a measure of verbal fluency, scores from baseline to Time 3 (16 weeks after baseline) will be assessed. Measured as number of words produced and adjusted for age and education. Higher words produced suggests greater verbal fluency performance.

次要结局

  • Interleukin-13 concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Interferon gamma concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Interleukin-1 β concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Interleukin-4 concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Granulocyte-macrophage colony-stimulating factor concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Interleukin-10 concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Interleukin-8 concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Interleukin-2 concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Interleukin-5 concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Interleukin-6 concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Interleukin-12 concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Self-reported cognitive function(Baseline, Time 2 (8 weeks after baseline), and Time 3 (16 weeks after baseline).)
  • Anxiety Symptoms(Baseline, Time 2 (8 weeks after baseline), and Time 3 (16 weeks after baseline).)
  • Interleukin-7 concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Tumor necrosis factor alpha concentration(Baseline, and Time 2 (8 weeks after baseline).)
  • Feelings of depression(Baseline, Time 2 (8 weeks after baseline), and Time 3 (16 weeks after baseline).)
  • Perceived Fatigue(Baseline, Time 2 (8 weeks after baseline), and Time 3 (16 weeks after baseline).)
  • Perceived stress(Baseline, Time 2 (8 weeks after baseline), and Time 3 (16 weeks after baseline).)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ashley M. Henneghan

Assistant Professor

University of Texas at Austin

研究点 (2)

Loading locations...

相似试验

Improving Brain Function After Breast Cancer Study | 临床试验